Search results for: 'modified nucleotides cap products'
-
R1017 EZ Cap™ mCherry mRNA (5mCTP, ψUTP)4 CitationSummary: mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
B7951 Aminoallyl-UTPSummary: Synthesize labeled cDNA and cRNA for fluorescence detection in gene microarrays. -
B7950 Aminoallyl-dUTPSummary: Labeling of DNA/cDNA via PCR and functions as a reactive site for subsequent labeling by reactive fluorescent probes. -
R1002 EZ Cap™ EGFP mRNASummary: EGFP mRNA with Cap 1 structure, providing higher transcription efficiency -
R1035 EZ Cap™ Fdx1 mRNASummary: Fdx1 mRNA with Cap 1 structure, providing high transcriptional efficiency -
R1027 EZ Cap™ OVA mRNASummary: Ovalbumin mRNA with Cap 1 structure, providing higher transcription efficiency -
R1020 EZ Cap™ EPO mRNA (ψUTP)Summary: Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation. -
R1016 EZ Cap™ EGFP mRNA (5-moUTP)17 CitationSummary: EGFP mRNA with Cap 1 structure, modified by 5-moUTP,providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1003 EZ Cap™ EGFP mRNA (m1Ψ)Summary: EGFP mRNA with Cap 1 structure, modified by m1Ψ,providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1036 EZ Cap™ Fdx1 mRNA (ψUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

